ArticleCEN case reports2026
Sequential cryoglobulinemia-associated glomerulonephritis and light-chain amyloidosis in monoclonal gammopathy of renal significance.
Article in CEN case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kidney disorders associated with monoclonal gammopathy are diagnostically challenging because diverse kidney lesions can occur during the disease course. Here, we report a man in his early 60s who presented with edema, proteinuria, and impaired kidney function. Kidney biopsy revealed cryoglobulinemia-associated glomerulonephritis. Although bone marrow examination showed no increase in plasma cells, the patient was diagnosed with monoclonal gammopathy of renal significance (MGRS) and treated with steroids and cryofiltration, resulting in transient improvement. Later, proteinuria worsened, and kidney function declined despite intensified steroid therapy. A repeat kidney biopsy demonstrated AL (lambda) amyloid deposition in the glomeruli, leading to a diagnosis of AL amyloidosis. This case illustrates that distinct kidney pathologies can emerge sequentially in patients with MGRS and underscores the importance of repeat kidney biopsies when clinical findings change.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.